Skip to main content
. 2026 Oct 14;100(11):e01001-26. doi: 10.1128/jvi.01001-26

Fig 1.

Diagram of a DMS workflow for nucleocapsid variants using a lentiviral construct, surface display with FACS sorting, PacBio and Illumina sequencing, and a heatmap showing escape scores by N site.

Deep mutational scanning (DMS) strategy. (A) Schematic of lentiviral construct used to generate a stable mammalian cell line. (B) Schematic for surface expression. First, nucleocapsid is expressed as a dimer on the surface of HEK293 cells. Cells are then incubated with the RAT antibody, followed by incubation with an appropriate secondary antibody and an anti-Myc antibody to control for surface expression levels. (C) DMS workflow. Starting from a barcoded library of nucleocapsid, in step 1, PacBio sequencing was applied to generate a lookup table associating nucleocapsid variants with barcodes. Therefore, all following assays could proceed using short-read Illumina sequencing, as described in step 2. First, the barcoded library was transduced into HEK293 cells, then exposed to the anti-N, anti-Myc, and secondary antibodies. FACS was then used to select for weakest binders, which comprises our escape population. RNA was extracted from this population as well as from an unsorted reference population. Both sets of RNA were reverse-transcribed and amplified, then the barcodes were sequenced. By referring to the lookup table, nucleocapsid variants were inferred from the barcodes. The data were then filtered and, by comparing the escape and reference population statistics, an escape score per nucleocapsid variant was generated. These scores can be visualized using heatmaps. CMV, cytomegalovirus; FACS, fluorescence-activated cell sorting; GFP, green fluorescent protein; IRES, internal ribosomal entry site; LTR, long terminal repeat; nt, nucleotide; SP, signal peptide; TM, transmembrane.